Related Experiment Video
Updated: Aug 4, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
NO-NSAIDs and cancer: promising novel agents
B Rigas1, H Kalofonos, E Lebovics
1American Health Foundation, 1 Dana Road, Valhalla, NY 10595, USA. brigas@ahf.org
Nitric oxide-donating nonsteroidal anti-inflammatory drugs (NO-donating NSAIDs) show promise for cancer prevention and treatment. Their enhanced safety and efficacy, particularly in colon cancer, stem from affecting key carcinogenic pathways.
Area of Science:
- Oncology
- Pharmacology
- Gastroenterology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) have limitations in cancer prevention and treatment.
- Nitric oxide (NO) donation may enhance NSAID safety and efficacy.
- Colon cancer presents significant challenges in prevention and therapy.
Purpose of the Study:
- To explore the potential applications of NO-donating NSAIDs in human cancer.
- To evaluate the chemopreventive effects of NO-donating NSAIDs against colon cancer.
- To assess the efficacy and safety of NO-donating NSAIDs in cancer treatment and symptom management.
Main Methods:
- Review of preclinical models and existing evidence on NO-donating NSAIDs.
- Analysis of molecular pathways involved in colon carcinogenesis.
- Comparison of NO-donating NSAIDs with traditional NSAIDs.
Main Results:
- NO-donating NSAIDs demonstrate enhanced safety and efficacy compared to traditional NSAIDs.
- Evidence suggests potential for colon cancer chemoprevention.
- NO-donating NSAIDs impact critical pathways in colon cancer development.
Conclusions:
- NO-donating NSAIDs offer a promising therapeutic strategy for colon cancer prevention.
- These agents may overcome limitations associated with conventional NSAIDs.
- Further research into NO-donating NSAIDs for cancer treatment and pain management is warranted.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists